We are live on ! Find out more
BSX icon

Boston Scientific

1,066 hedge funds and large institutions have $71.5B invested in Boston Scientific in 2023 Q2 according to their latest regulatory filings, with 134 funds opening new positions, 401 increasing their positions, 359 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 134 | Existing positions closed: 63

20% more funds holding in top 10

Funds holding in top 10: 2530 (+5)

12% more repeat investments, than reductions

Existing positions increased: 401 | Existing positions reduced: 359

9% more capital invested

Capital invested by funds: $65.6B → $71.5B (+$5.9B)

7% more funds holding

Funds holding: 9961,066 (+70)

0.9% less ownership

Funds ownership: 91.43%90.53% (-0.9%)

9% less call options, than puts

Call options by funds: $295M | Put options by funds: $326M

Holders
1,066
Holders Change
+70
Holders Change %
+7.03%
% of All Funds
16.74%
Holding in Top 10
30
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+20%
% of All Funds
0.47%
New
134
Increased
401
Reduced
359
Closed
63
Calls
$295M
Puts
$326M
Net Calls
-$30.8M
Net Calls Change
+$36.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
$526M +$7.06M +135,093 +1%
VOYA Investment Management
27
VOYA Investment Management
Georgia
$521M +$227M +4,353,541 +82%
N
28
Nuveen
North Carolina
$506M +$69.1M +1,323,650 +16%
Lazard Asset Management
29
Lazard Asset Management
New York
$497M -$116M -2,226,793 -20%
Arrowstreet Capital
30
Arrowstreet Capital
Massachusetts
$481M +$18.9M +362,495 +4%
Ameriprise
31
Ameriprise
Minnesota
$429M -$91M -1,741,971 -18%
Aberdeen Group
32
Aberdeen Group
United Kingdom
$421M -$4.42M -84,684 -1%
Charles Schwab
33
Charles Schwab
California
$403M -$4.54K -87 -0%
Fidelity International
34
Fidelity International
Bermuda
$390M -$83M -1,589,254 -18%
Newport Trust Company
35
Newport Trust Company
District of Columbia
$371M -$3.14M -60,076 -0.9%
Canada Pension Plan Investment Board
36
Canada Pension Plan Investment Board
Ontario, Canada
$365M +$18.4M +351,980 +6%
UBS AM
37
UBS AM
Illinois
$362M
Holocene Advisors
38
Holocene Advisors
New York
$328M +$89.7M +1,717,569 +39%
Impax Asset Management Group
39
Impax Asset Management Group
United Kingdom
$326M -$49.2M -941,770 -13%
UBS Group
40
UBS Group
Switzerland
$309M +$2.28M +43,643 +0.8%
Swiss National Bank
41
Swiss National Bank
Switzerland
$281M -$25.8M -493,200 -9%
FCM
42
Farallon Capital Management
California
$273M -$139M -2,660,000 -35%
Ninety One (UK)
43
Ninety One (UK)
United Kingdom
$272M -$1.28M -24,490 -0.5%
SEI Investments
44
SEI Investments
Pennsylvania
$263M +$31.2M +597,940 +14%
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$248M +$29.3M +560,880 +14%
Winslow Capital Management
46
Winslow Capital Management
Minnesota
$238M +$230M +4,399,440 New
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$230M +$84.2M +1,611,740 +62%
PI
48
Putnam Investments
Massachusetts
$216M -$38.7M -741,775 -16%
AM
49
AGF Management
Ontario, Canada
$214M +$86.3M +1,651,426 +72%
Fisher Asset Management
50
Fisher Asset Management
Washington
$208M +$2.68M +51,352 +1%

BSX Hedge Fund Activity: Q2 2023 in Review

1,066 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2023, worth a combined $71.5B — up 9% from $65.6B a quarter earlier.

Buyers outnumbered sellers: 134 funds opened new BSX positions and 63 closed out — a net gain of 71 holders — while 401 added to existing stakes and 359 trimmed.

The largest buyer was Invesco, adding an estimated $285M. The largest seller was JP Morgan Chase, cutting an estimated $549M.

  • 1,066 institutional investors held Boston Scientific (BSX) as of Q2 2023, up from 996 in Q1 2023.
  • Funds reported $71.5B of Boston Scientific stock for Q2 2023, up 9% quarter-over-quarter.
  • 134 funds opened new Boston Scientific positions in Q2 2023 and 63 closed out, a net change of +71 holders.
  • The largest Boston Scientific buyer in Q2 2023 was Invesco, an estimated $285M added.
  • The largest Boston Scientific seller in Q2 2023 was JP Morgan Chase, an estimated $549M sold.

Based on aggregated 13F filings for Q2 2023.